The benchmarks disregarded the promising beginning of the latest earnings season and focused on the fact that another significant pharma company halted the trials of a potential #COVID-19 vaccine. USA30 fell 0.55% while USA500 was down 0.61%. TECH100 slipped 0.10%.
Crude Oil and Brent gained 0.4%, ending the session at $39.56 per barrel and $41.88.
Gold lost 1.8% to $1,894.60 per ounce.
The Dollar Index rose 0.5% to 93.55.
Asia and Australia
Japan225 lost 0.07% amid the hiccup in the trials of a potential COVID-19 #vaccine from Johnson & Johnson.
Down under, Australia200 gained 1.18%, after the country is seeking to resolve the ban imposed by China on the Australian coal imports.
USD/JPY gained 0.24% to 105.55.
Germany30 and UK100 lost 0.4% each. France40 fell 0.5%. The drop was caused by the fact that the new wave of infections could negatively impact the ongoing economic recovery.
EUR/USD traded at 1.1785 after it lost 0.2%.
Sources: reuters.com, investing.com